54 242 (Capecitabine 150 mg)
Pill imprint 54 242 has been identified as Capecitabine 150 mg.
Capecitabine is used in the treatment of colorectal cancer; breast cancer, metastatic; breast cancer; pancreatic cancer; stomach cancer (and more), and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Capecitabine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about capecitabine
- Other brands: Xeloda
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.